The COMPASS Study: A Study of Volanesorsen (Formally ISIS-APOCIIIRx) in Patients With Hypertriglyceridemia
Clinical trial NCT02300233 · COMPLETED
Trial details
- NCT number
- NCT02300233
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-05
- Primary completion
- 2016-07-27
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.